10 days ago
GH
AnalystsDavid WestenbergDavid Westenberg's Stock Forecasts
AnalystsDavid Westenberg
Analyst Ranking
Top 7%
#320 out of 5084 analysts
Average Return
+17.67%
Win Rate
58%68 out of 118
Risk vs Reward
Poor
Good
David Westenberg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +204.75% | $42.33 | $129.00 | 2023-10-16 - 2024-10-15 | Strong Buy |
Adaptive Biotechnologies CorpADPT | +160.55% | $6.49 | $16.91 | 2024-11-11 - 2025-10-30 | Strong Buy |
Natera IncNTRA | +133.26% | $47.08 | $109.82 | 2023-05-30 - 2024-05-29 | Strong Buy |
Neogenomics IncNEO | +122.80% | $8.07 | $17.98 | 2022-06-02 - 2023-06-02 | Strong Buy |
Guardant Health IncGH | +120.39% | $41.93 | $92.41 | 2025-05-06 - 2025-10-30 | Strong Buy |
David Westenberg Analyst Color
Get additional color on David Westenberg's coverage of popular stocks
17 days ago
ADPT
2 months ago
WGS
3 months ago
NTRA
3 months ago
ADPT
3 months ago
WGS
6 months ago
GH
8 months ago
TEM
8 months ago
NTRA
a year ago
ADPT
a year ago
EXAS
a year ago
GH
a year ago
NTRA
a year ago
NTRA
2 years ago
ZTS
3 years ago
NVTAQ
3 years ago
CTKB
David Westenberg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Quest Diagnostics IncDGX | 8 | Hold | $200.00 | +13.80% | Maintains | 5 days ago |
Tempus Ai IncTEM | 5 | Hold | $105.00 | +21.71% | Maintains | 10 days ago |
Guardant Health IncGH | 10 | Strong Buy | $90.00 | -2.61% | Maintains | 10 days ago |
Neogen CorpNEOG | 13 | Hold | $6.50 | +8.33% | Reiterates | 16 days ago |
Adaptive Biotechnologies CorpADPT | 12 | Strong Buy | $20.00 | +18.27% | Maintains | 17 days ago |
Exact Sciences CorpEXAS | 12 | Strong Buy | $70.00 | +10.72% | Maintains | 24 days ago |
Genedx Holdings CorpWGS | 3 | Strong Buy | $140.00 | +6.46% | Maintains | 2 months ago |
10x Genomics IncTXG | 2 | Hold | $15.00 | +20.58% | Initiates Coverage On | 2 months ago |
Pacific Biosciences Of California IncPACB | 9 | Hold | $1.50 | -22.68% | Maintains | 3 months ago |
Zoetis IncZTS | 12 | Strong Buy | $215.00 | +49.20% | Maintains | 3 months ago |
Idexx Laboratories IncIDXX | 8 | Hold | $700.00 | +11.37% | Maintains | 3 months ago |
Elanco Animal Health IncELAN | 10 | Hold | $18.00 | -20.25% | Maintains | 3 months ago |
Natera IncNTRA | 16 | Strong Buy | $220.00 | +13.86% | Maintains | 3 months ago |
Neogenomics IncNEO | 10 | Strong Buy | $11.00 | +13.52% | Maintains | 3 months ago |
Fulgent Genetics IncFLGT | 9 | Hold | $21.00 | -7.00% | Maintains | 3 months ago |
Illumina IncILMN | 15 | Strong Buy | $185.00 | +86.85% | Maintains | 6 months ago |
Labcorp Holdings IncLH | 4 | Hold | $280.00 | +10.97% | Maintains | 6 months ago |
Akoya Biosciences IncAKYA | 8 | Hold | $1.65 | +27.91% | Maintains | 7 months ago |
Cytek Biosciences IncCTKB | 9 | Strong Buy | $8.00 | +109.42% | Maintains | 8 months ago |
Insight Molecular Diagnostics IncIMDX | 7 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Invitae CorpNVTAQ | 5 | Strong Sell | $0.30 | N/A | Maintains | 2 years ago |
Heska CorpHSKA | 6 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Covetrus IncCVET | 1 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Petiq IncPETQ | 1 | Strong Buy | $44.00 | N/A | Maintains | 5 years ago |
Quidelortho CorpQDEL | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Trupanion IncTRUP | 1 | Hold | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.